It’s a green light for GreenLight as RNA pioneer becomes industrial biotech’s latest billion dollar SPAC baby
So, it’s a surprise but not a shock that GreenLight Biosciences is taking part in the latest SPACmania merger, and is funding with Environmental Impact Acquisition Corp. — and will emerge sometime in the next several months on NASDAQ as the sector’s latest billion-dollar baby. The initial valuation in the deal is $1.2 billion, more […]











